physIQ Heart Rhythm and Respiratory Module vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

physIQ Heart Rhythm and Respiratory Module

by physIQ

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

These tools are adjacent rather than direct competitors, as they leverage fundamentally different data types and provide distinct insights. physIQ's module focuses on continuous physiological monitoring from wearable biosensors for real-time heart rhythm and respiration analysis, whereas ClearRead CT specializes in AI-enhanced analysis of static CT scans for pulmonary nodule detection and coronary artery calcification scoring. While both serve cardiology and pulmonology, they address different clinical needs: dynamic physiological changes versus static imaging diagnostics.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if your primary need is continuous, real-time remote monitoring of patients using wearable biosensor data. This tool excels at establishing personalized physiological baselines and detecting subtle changes or early signs of cardiac and respiratory decompensation, making it ideal for proactive patient management outside of traditional clinical settings.

View physIQ Heart Rhythm and Respiratory Module →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the accuracy and efficiency of cardiothoracic CT scan interpretation. This AI suite is best suited for radiologists seeking to improve pulmonary nodule detection, characterize nodules, perform coronary artery calcification scoring, and reduce reading times through advanced AI and patented vessel suppression technology.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	physIQ Heart Rhythm and Respiratory Module	ClearRead CT
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud-based platform	On-premise (stand-alone server, virtual machine) and Cloud
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ClearRead CT

ClearRead CT is designed for seamless integration into existing PACS workflows, directly enhancing the user experience for radiologists by streamlining image review. Its features aim to reduce reading times and improve efficiency within the established diagnostic process.

Clinical Value

ClearRead CT

ClearRead CT provides quantifiable clinical benefits, including a 29% reduction in missed actionable nodules and up to 36% reduced reading times, directly improving diagnostic accuracy and efficiency for critical conditions. Both tools are FDA-cleared, but Tool B offers more specific metrics for its impact on patient outcomes and workflow.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to compare their cost-effectiveness or overall value proposition based on publicly available data. Neither provides transparent pricing details.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

PhysIQ explicitly states it is an 'enterprise-ready cloud platform' and definitively confirms both BAA and HIPAA compliance. While ClearRead CT offers deployment flexibility and operates with major healthcare institutions, its compliance claims are less explicit, stating 'likely, contact vendor for details'.

Innovation

physIQ Heart Rhythm and Respiratory Module

PhysIQ's focus on 'digital medicine' and generating 'unprecedented health insight using continuous wearable biosensor data and advanced analytics' represents a more foundational innovation in proactive, personalized health monitoring. Its ability to learn individual patient baselines and detect subtle physiological changes from wearables signifies a broader paradigm shift in care delivery.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded specific details regarding public-facing support resources or comprehensive documentation for either product. As enterprise solutions, both likely offer direct client support, but comparative information is unavailable.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	physIQ Heart Rhythm and Respiratory Module	ClearRead CT
Name	physIQ Heart Rhythm and Respiratory Module	ClearRead CT
Company	physIQ	RIVERAIN TECHNOLOGIES
Primary Data Source / Modality	Continuous wearable biosensor data	CT scans
Key Functionality - Cardiology	Calculates heart rate and heart rate variability, Detects atrial fibrillation	Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs)
Key Functionality - Pulmonology	Determines respiration rate	Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for patient monitoring (Tool A) versus diagnostic imaging interpretation (Tool B)?

Tool A, physIQ Heart Rhythm and Respiratory Module, integrates into continuous remote patient monitoring workflows, providing real-time physiological insights from wearable data for proactive management in cardiology, critical care, and pulmonology settings. Tool B, ClearRead CT, seamlessly integrates into radiology PACS workflows as an additional series, enhancing CT scan interpretation for pulmonary nodule detection and coronary artery calcification scoring without requiring a separate viewer or login.

What is the depth of EHR integration for each tool, and how does it facilitate documentation and data access for physicians?

Tool A is designed to be integrated by the customer into an end-to-end system, often using a Python middleware script to access biosensor data for clinician display, implying a need for custom EHR integration. Tool B provides output in DICOM format, readable in PACS, and supports structured reporting and HL-7 integration, allowing for direct incorporation of findings into radiology reports and patient data management systems.

What are the key performance metrics (e.g., sensitivity, specificity) for detecting physiological changes (Tool A) or pulmonary nodules/CAC (Tool B)?

Tool A utilizes AI-based personalized physiology analytics to detect subtle physiological changes and early signs of decompensation, including atrial fibrillation and respiration rate, by learning individual patient baselines. Tool B has demonstrated improved detection accuracy for pulmonary nodules, with studies showing a significant increase in per-nodule sensitivity (e.g., from 63% to 79%) and a 29% reduction in missed actionable nodules, along with high agreement for CAC scoring.

For which specific clinical scenarios or patient populations is each tool most impactful, given their distinct data sources and analytical approaches?

Tool A is most impactful for continuous, remote physiological monitoring of adult patients in subacute clinical and non-clinical settings, particularly for managing chronic cardiac or respiratory conditions and enabling proactive intervention. Tool B is highly impactful for radiologists and cardiologists interpreting chest CT scans for pulmonary nodule detection and characterization, as well as coronary artery calcification scoring, especially in lung cancer screening programs and for incidental findings.

What is the expected learning curve for physicians to effectively utilize and trust the insights provided by each tool, and what support is available?

Tool A's learning curve would likely involve understanding continuous data trends and interpreting alerts from its personalized physiology analytics, with usability centered on dashboard interpretation. Tool B is designed for seamless PACS integration and concurrent reading, aiming for a workflow-friendly experience, and Riverain Technologies provides comprehensive customer support including FAQs, manuals, and direct contact options.

Beyond standard compliance, what advanced security features and audit-trail capabilities does each tool offer to ensure data integrity and accountability for clinical decisions, especially for multi-site rollouts?

Tool A is a CFR Part 11-compliant cloud platform that processes sensitive biosensor data to a secure cloud, emphasizing enterprise readiness. Tool B is ISO27001 certified and offers structured reporting and HL-7 integration, which facilitates auditability within existing hospital systems, with proven enterprise-wide and multi-site deployment capabilities across various healthcare institutions.